A novel combination treatment of armed oncolytic adenovirus expressing IL-12 and GM-CSF with radiotherapyin murine hepatocarcinoma

Journal of Radiation Research

Volumn 52, Issue 5, 2011, Pages 646-654

  Kim, Wonwoo ^a   Seong, Jinsil ^a   Oh, Hae Jin ^a   Koom, Woong Sub ^a   Choi, Kyung Joo ^b   Yun, Chae Ok ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BLOOD VESSELS; DISEASES; MACROPHAGES; PATHOLOGY; RADIATION; RADIOTHERAPY; TUMORS; VIRUSES;

ANTI-TUMORS; COMBINATION TREATMENTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS; HEPATOCARCINOMA; INTERLEUKIN-12; INTRATUMORAL INJECTION; LUNG METASTASIS; MICROVESSEL DENSITY; ONCOLYTIC VIRUS; TUMOR GROWTH;

CELL DEATH;

ADENOVIRIDAE; MURINAE; MUS;

EID: 80053355731     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.10185     Document Type: Article

References (33)

1. Lamfers ML, et al (2007) Differential effects of combined Ad5-Δ'24RGD and radiation therapy in vitro versus in vivo models of malignant glioma. Clin Cancer Res 13: 7451-7458.
2. Breitbach CJ, et al (2007) Targeted inflammation during oncolytic virus therapy severely compromised tumor blood flow. Mol Ther 15: 1686-1693.
3. Yoon AR, et al (2006) Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Hum Gene Ther 17: 379-390.
4. Advani SJ, et al (2006) ReVOLT: Radiation-enhanced viral oncolytic therapy. Int J Radiat Oncol Biol Phys 66: 637-646.
5. Qian J, et al (2005) Ionizing radiation-induced adenovirus infection is mediated by dynamin 2. Cancer Res 65: 5493-5497.
6. Liu C, et al (2007) Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme. Clin Cancer Res 13: 7155-7165.
7. Nishizaki M, et al (2001) Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res 7: 2887-2897.
8. Dilley J, et al (2005) Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity. Cancer Gene Ther 12: 715-722.
9. Sgadari C, Angiolillo AL and Tosato G (1996) Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87: 3877-3882.
10. Choi KJ, et al (2006) Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Gene Ther 13: 1010-1020.
11. Wang Z, et al (2001) Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma. Cancer Gene Ther 8: 751-758.
12. Milas L, et al (1974) Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 34: 61-71.
13. Kim J, et al (2007) E1A-and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects. Hum Gene Ther 18: 773-786.
14. Lee YS, et al (2006) Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Clin Cancer Res 12: 5859-5868.
15. Milas L, et al (1999) Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 59(1):107-114.
16. Kim W, et al (2007) Enhancement of tumor radioresponse by wortmannin in C3H/HeJ hepatocarcinoma. J Radiat Res 48: 187-195.
17. Fidler IJ and Hart IR (1981) The origin of metastatic heterogeneity in tumors. Eur J Cancer 17: 487-494.
18. Weidner N (1995) Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19.
19. Seong S, Kim SH and Suh CO (2002) Enhancement of radioresponse of murine tumors by ERK inhibitor. Ann N Y Acad Sci 973: 371-373.
20. Kim J, Seong J and Kim SH (2004) Enhancement of tumor response by farnesyltransferase inhibitor in C3H/HeJ hepatocarcinoma. Ann N Y Acad Sci 1030: 95-102.
21. Cao G, et al (2001) Adenovirus-mediated interferon-β gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cancer Gene Ther 8: 497-505.
22. Thorne SH, et al (2006) Selective intratumoral amplification of an antiangiogenic vector by an oncolytic virus produces enhanced antivascular and anti-tumor efficacy. Mol Ther 13: 938-946.
23. Yao L, et al (1999) Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 93: 1612-1621.
24. Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8: S62-S67.
25. Shi YH and Fang WG (2004) Hypoxia-inducible factor-1 in tumor angiogenesis. World J Gastroenterol 10: 1082-1087.
26. Theodoropoulos GE, et al (2006) Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis 21: 248-257.
27. Moeller BJ, et al (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 5: 429-441.
28. Kamrava M, et al (2009) Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? Mol BioSyst 5: 1262-1270.
29. Nikitina EY and Gabrilovich DI (2001) Combination of γ-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: Approach to treatment of advanced stage cancer. Int J Cancer 94: 825-833.
30. Teitz TS, et al (2003) Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Cancer Res 63: 8466-8475.
31. Lee J, et al (2000) Alteration of tumour response to radiation by interleukin-2 gene transfer. Br J Cancer 82: 937-944.
32. Adorini L (1999) Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases. Cell Mol Life Sci 55: 1610-1625.
33. Chen LY, Lin YL and Chiang BL (2008) Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells. Clin Exp Immunol 151: 174-181.